{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:30:11Z","timestamp":1772775011515,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ajt.2023.07.013","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T06:32:39Z","timestamp":1690353159000},"page":"1961-1971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Body surface area compared to body weight dosing of valganciclovir is associated with increased toxicity in pediatric solid organ transplantation recipients"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-0353","authenticated-orcid":false,"given":"Salih","family":"Demirhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0457-7689","authenticated-orcid":false,"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5976-6612","authenticated-orcid":false,"given":"Kristen G.","family":"Valencia Deray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9577-8162","authenticated-orcid":false,"given":"Claire E.","family":"Bocchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-5221","authenticated-orcid":false,"given":"Lara","family":"Danziger-Isakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3051-2041","authenticated-orcid":false,"given":"Samantha","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3452-0666","authenticated-orcid":false,"given":"Tanvi S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9290-6667","authenticated-orcid":false,"given":"Gilad","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9248-780X","authenticated-orcid":false,"given":"Juri","family":"Boguniewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8882-6946","authenticated-orcid":false,"given":"Samantha","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2853-2581","authenticated-orcid":false,"given":"Monica I.","family":"Ardura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5247-5399","authenticated-orcid":false,"given":"Gabriela M.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-5507","authenticated-orcid":false,"given":"Jose","family":"Ferrolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1628-8446","authenticated-orcid":false,"given":"Marc","family":"Foca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9974-0786","authenticated-orcid":false,"given":"Betsy C.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajt.2023.07.013_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14493","article-title":"Incidence of cytomegalovirus DNAemia in pediatric kidney, liver, and heart transplant recipients: efficacy and risk factors associated with failure of weight-based dosed valganciclovir prophylaxis","volume":"27","author":"Liverman","year":"2023","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2023.07.013_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14220","article-title":"CMV infection and management among pediatric solid organ transplant recipients","volume":"26","author":"Downes","year":"2022","journal-title":"Pediatr Transplant"},{"issue":"suppl 1","key":"10.1016\/j.ajt.2023.07.013_bib3","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/infdis\/jiz454","article-title":"Cytomegalovirus infection in solid organ and hematopoietic cell transplantation: state of the evidence","volume":"221","author":"Haidar","year":"2020","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.ajt.2023.07.013_bib4","article-title":"Cytomegalovirus in the transplant setting: where are we now and what happens next? A report from the International CMV Symposium 2021","volume":"24","author":"Kotton","year":"2022","journal-title":"Transpl Infect Dis A report from the International CMV Symposium"},{"issue":"1","key":"10.1016\/j.ajt.2023.07.013_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/ajt.16822","article-title":"Epidemiology and long-term outcomes of cytomegalovirus DNAemia and disease in pediatric solid organ transplant recipients","volume":"22","author":"Valencia Deray","year":"2022","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2023.07.013_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2007.03.009","article-title":"Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis","volume":"13","author":"Battiwalla","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2023.07.013_bib7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.ajt.2023.07.013_bib8","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/TP.0b013e3181a19cda","article-title":"A\u00a0hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients","volume":"87","author":"Madan","year":"2009","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajt.2023.07.013_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13232","article-title":"Evaluation of a change in cytomegalovirus prevention strategy following pediatric solid organ transplantation","volume":"22","author":"Pangonis","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ajt.2023.07.013_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1098434","article-title":"Prevention and management of CMV infection in pediatric solid organ transplant recipients","volume":"11","author":"Balani","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ajt.2023.07.013_bib11","series-title":"VALCYTE (valganciclovir hydrochloride) tablets. Valcyte (valganciclovir hydrochloride) for oral solution, package insert","year":"2017"},{"key":"10.1016\/j.ajt.2023.07.013_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1057352","article-title":"National survey of prevention and management of CMV infection in pediatric kidney transplantation in comparison to clinical practice guidelines","volume":"10","author":"Madden","year":"2022","journal-title":"Front Pediatr"},{"issue":"9","key":"10.1016\/j.ajt.2023.07.013_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13369","article-title":"A\u00a0national survey of valganciclovir dosing strategies in pediatric organ transplant recipients","volume":"32","author":"Shaikh","year":"2018","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2023.07.013_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/petr.12030","article-title":"Valganciclovir dosing using area under the curve calculations in pediatric solid organ transplant recipients","volume":"17","author":"Villeneuve","year":"2013","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2023.07.013_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/psp4.12363","article-title":"Pediatric dosing of ganciclovir and valganciclovir: how model-based simulations can prevent underexposure and potential treatment failure","volume":"8","author":"Jorga","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"8","key":"10.1016\/j.ajt.2023.07.013_bib16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/INF.0000000000001595","article-title":"Valganciclovir dosing for cytomegalovirus prophylaxis in pediatric solid-organ transplant recipients: a prospective pharmacokinetic study","volume":"36","author":"Peled","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.ajt.2023.07.013_bib17","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1111\/ajt.17171","article-title":"Antiviral toxicities in pediatric solid organ transplant recipients","volume":"22","author":"Hayes","year":"2022","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2023.07.013_bib18","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/TP.0000000000002632","article-title":"Efficacy and safety of a weight-based dosing regimen of valganciclovir for cytomegalovirus prophylaxis in pediatric solid-organ transplant recipients","volume":"103","author":"Pappo","year":"2019","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2023.07.013_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ajt.2023.07.013_bib20","series-title":"Collaborative study to evaluate the proposed 1st [first] WHO international standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays","author":"Fryer","year":"2010"},{"issue":"2","key":"10.1016\/j.ajt.2023.07.013_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jmoldx.2012.09.007","article-title":"Standard reference material 2366 for measurement of human cytomegalovirus DNA","volume":"15","author":"Haynes","year":"2013","journal-title":"J\u00a0Mol Diagn"},{"issue":"2","key":"10.1016\/j.ajt.2023.07.013_bib22","first-page":"164","article-title":"Incidence of cytomegalovirus DNAemia in pediatric post-renal transplant patients receiving Weight-Based vs Body Surface area-based valganciclovir chemoprophylaxis","volume":"27","author":"Thomas","year":"2022","journal-title":"J\u00a0Pediatr Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ajt.2023.07.013_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13713","article-title":"Comparison of standard versus low-dose valganciclovir regimens for cytomegalovirus prophylaxis in high-risk liver transplant recipients","volume":"23","author":"Bixby","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ajt.2023.07.013_bib24","series-title":"FDA Drug Safety Communication: new dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients","year":"2010"},{"issue":"12","key":"10.1016\/j.ajt.2023.07.013_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01192-19","article-title":"Population pharmacokinetics of ganciclovir after valganciclovir in renal transplant children","volume":"63","author":"Facchin","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ajt.2023.07.013_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01597-22","article-title":"Limited sampling strategies to predict ganciclovir exposure after valganciclovir administration and to reduce monitoring constraints in renal transplant children","volume":"67","author":"Facchin","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ajt.2023.07.013_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/FTD.0000000000001050","article-title":"Subtherapeutic exposure of ganciclovir in children despite appropriate dosing: A short communication","volume":"45","author":"Marfil","year":"2023","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.ajt.2023.07.013_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13609","article-title":"Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers","volume":"24","author":"Paulsen","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2023.07.013_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/cid\/ciaa1713","article-title":"Letermovir and maribavir for the treatment and prevention of cytomegalovirus infection in solid organ and stem cell transplant recipients","volume":"73","author":"Imlay","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ajt.2023.07.013_bib30","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMoa1714656","article-title":"Maribavir for preemptive treatment of cytomegalovirus reactivation","volume":"381","author":"Maertens","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajt.2023.07.013_bib31","unstructured":"LIVTENCITY (maribavir) tablets, for oral use. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/215596lbl.pdf. Accessed April 10, 2023."},{"issue":"1","key":"10.1016\/j.ajt.2023.07.013_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2023.9106","article-title":"Letermovir vs valganciclovir for prophylaxis of cytomegalovirus in high-risk kidney transplant recipients: a randomized clinical trial","volume":"330","author":"Limaye","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ajt.2023.07.013_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13570","article-title":"Letermovir prophylaxis in solid organ transplant-assessing CMV breakthrough and tacrolimus drug interaction","volume":"23","author":"Winstead","year":"2021","journal-title":"Transpl Infect Dis"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613523005841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613523005841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T05:25:45Z","timestamp":1733030745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613523005841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1600613523005841"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2023.07.013","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Body surface area compared to body weight dosing of valganciclovir is associated with increased toxicity in pediatric solid organ transplantation recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2023.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}